🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This pilot study investigates whether advanced diffusion-weighted MRI (ADW-...
Status
Recruiting
Location
University Hospital Basel
Start Date
2022-11-24
Trial ID
NCT05911230
Treatments Being Tested
The study described in this protocol is a Phase 1, single center clinical t...
Status
Withdrawn
Location
The University of Texas MD Anderson Cancer Centre
Start Date
2026-02
Trial ID
NCT05634954
Treatments Being Tested
FLIP topography has been FDA cleared to evaluate a variety of esophageal co...
Status
Withdrawn
Location
Stanford Healthcare
Start Date
2018-01-01
Trial ID
NCT03270722
Treatments Being Tested
Pancreatic cancer remains one of the most aggressive cancer types. Target-s...
Status
Recruiting
Location
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Start Date
2024-11-20
Trial ID
NCT06602037
Treatments Being Tested
RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of...
Status
Terminated
Location
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Start Date
2008-07
Trial ID
NCT00727532
Treatments Being Tested
The purpose of this study is to see how well Photon Counting CT (PCCT) and ...
Status
Recruiting
Location
Duke University Medical Center
Start Date
2026-03-27
Trial ID
NCT07495332
Treatments Being Tested
The purpose of this study is to evaluate the safeness and effectiveness of ...
Status
Completed
Location
Biological treatment center in Fuda cancer hospital
Start Date
2015-01
Trial ID
NCT02338700
Treatments Being Tested
The investigators intend to examine the effects of ocrelizumab use in Afric...
Status
Recruiting
Location
Wayne State University
Start Date
2021-11-20
Trial ID
NCT04458688
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Withdrawn
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2025-04-15
Trial ID
NCT06094842
This study will use imaging to look at tumor response to erlotinib (Part I)...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00729742
Treatments Being Tested